Neuralstem Receives Patent Allowance for Compounds that Promote Neurogenesis

Neuralstem has received a patent allowance for compounds they have developed that promote the growth of neurons. Neuralstem is also working on a potential ALS therapy, currently under IND review at the FDA.

Click here for more information

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail